WO2002040963A3 - Biologically active composites and methods for their production and use - Google Patents

Biologically active composites and methods for their production and use Download PDF

Info

Publication number
WO2002040963A3
WO2002040963A3 PCT/US2001/049948 US0149948W WO0240963A3 WO 2002040963 A3 WO2002040963 A3 WO 2002040963A3 US 0149948 W US0149948 W US 0149948W WO 0240963 A3 WO0240963 A3 WO 0240963A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
biologically active
production
disclosed
composites
Prior art date
Application number
PCT/US2001/049948
Other languages
French (fr)
Other versions
WO2002040963A2 (en
Inventor
Jeffrey G Marx
Erik M Erbe
Original Assignee
Vita Special Purpose Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/939,505 external-priority patent/US6736799B1/en
Application filed by Vita Special Purpose Corp filed Critical Vita Special Purpose Corp
Priority to AU2002241691A priority Critical patent/AU2002241691A1/en
Priority claimed from US10/035,797 external-priority patent/US7045125B2/en
Publication of WO2002040963A2 publication Critical patent/WO2002040963A2/en
Publication of WO2002040963A3 publication Critical patent/WO2002040963A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406Antibiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • A61L2300/414Growth factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43Hormones, e.g. dexamethasone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64Animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Biologically active composites containing calcium phosphate, more specifically beta-tri-calcium phosphate, and methods of preparing the same are disclosed herein. Also disclosed are methods of restoring an osseous void and complimentary kits for the disclosed composites.
PCT/US2001/049948 2000-10-24 2001-10-23 Biologically active composites and methods for their production and use WO2002040963A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002241691A AU2002241691A1 (en) 2000-10-24 2001-10-23 Biologically active composites and methods for their production and use

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24290600P 2000-10-24 2000-10-24
US60/242,906 2000-10-24
US09/939,505 US6736799B1 (en) 2000-10-24 2001-08-24 Delivery device for biological composites and method of preparation thereof
US09/939,505 2001-08-24
US10/035,797 US7045125B2 (en) 2000-10-24 2001-10-23 Biologically active composites and methods for their production and use

Publications (2)

Publication Number Publication Date
WO2002040963A2 WO2002040963A2 (en) 2002-05-23
WO2002040963A3 true WO2002040963A3 (en) 2003-01-16

Family

ID=27364903

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/049948 WO2002040963A2 (en) 2000-10-24 2001-10-23 Biologically active composites and methods for their production and use

Country Status (2)

Country Link
AU (1) AU2002241691A1 (en)
WO (1) WO2002040963A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9283074B2 (en) 2002-06-13 2016-03-15 Kensey Nash Bvf Technology, Llc Devices and methods for treating defects in the tissue of a living being

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020114795A1 (en) 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
US6981948B2 (en) 2002-11-18 2006-01-03 Depuy Spine, Inc. Bone marrow aspiration system
US7993578B2 (en) 2004-10-29 2011-08-09 Depuy Spine, Inc. Methods and kits for aseptic filling of products

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4065360A (en) * 1976-04-21 1977-12-27 Kreb Iii Robert J Culturing syringe device
US4801263A (en) * 1986-05-27 1989-01-31 Clark William C Osseous implant syringe
US5772665A (en) * 1993-11-03 1998-06-30 Astra Aktiebolag Device for mixing a pharmaceutical composition with an other agent
US5824084A (en) * 1996-07-03 1998-10-20 The Cleveland Clinic Foundation Method of preparing a composite bone graft
US5939039A (en) * 1997-01-16 1999-08-17 Orthovita, Inc. Methods for production of calcium phosphate

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4065360A (en) * 1976-04-21 1977-12-27 Kreb Iii Robert J Culturing syringe device
US4801263A (en) * 1986-05-27 1989-01-31 Clark William C Osseous implant syringe
US5772665A (en) * 1993-11-03 1998-06-30 Astra Aktiebolag Device for mixing a pharmaceutical composition with an other agent
US5824084A (en) * 1996-07-03 1998-10-20 The Cleveland Clinic Foundation Method of preparing a composite bone graft
US6049026A (en) * 1996-07-03 2000-04-11 The Cleveland Clinic Foundation Apparatus and methods for preparing an implantable graft
US5939039A (en) * 1997-01-16 1999-08-17 Orthovita, Inc. Methods for production of calcium phosphate

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9283074B2 (en) 2002-06-13 2016-03-15 Kensey Nash Bvf Technology, Llc Devices and methods for treating defects in the tissue of a living being

Also Published As

Publication number Publication date
AU2002241691A1 (en) 2002-05-27
WO2002040963A2 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
AU7511200A (en) Resorbable bone replacement and bone formation material
AU2002341920A1 (en) Chemical compounds
AU2002224927A1 (en) Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds
AU2002213273A1 (en) Stenoprophiluric matrices, and methods of making and using the same
CA2490820A1 (en) Articles, systems and methods for dispensing volatile materials into the environment
WO2004045464A3 (en) Medical devices
AU2003247798A1 (en) Nozzles and components thereof and methods for making the same
ATE320457T1 (en) POLYURETHANE SOLUTIONS WITH ALKOXYSIL STRUCTURAL UNITS
WO2003051886A8 (en) Pyrazolopyridazine derivatives
AU6362100A (en) Derivatized polyurethane compositions and methods of making
AU2002321292A1 (en) Hybrid membrane, method for the production thereof and use of said membrane
AU2001294228A1 (en) Benzimidazole compounds, process for producing the same and use thereof
WO2004004635A3 (en) Radiolabeled compounds and liposomes and their methods of making and using the same
WO2003042273A8 (en) Compounds containing quaternary carbons, medical devices, and methods
WO2002040963A3 (en) Biologically active composites and methods for their production and use
AU2004256947A1 (en) Hydroxyapatite calcium phosphate granules, method for preparing same and uses thereof
WO2001049651A3 (en) Aminomethyl-phenyl-cyclohexanone derivatives
WO2002024181A3 (en) The use of melatonin for induction of general anesthesia
AU4288300A (en) Unsupported flat linoleum structure and method of producing same
AU2003284691A1 (en) Calcium phosphate carrying protein, process for producing the same and sustained release protein preparation, artificial bone and tissue enginerring scaffold using the same
AU1411200A (en) Novel physiologically active substance, process for producing the same and utilization thereof
EP1436279B8 (en) Chemical compounds
AU2001271611A1 (en) Oxindole derivatives
AU2001277737A1 (en) Novel substance having physiological activity, process for producing the same, and use
AU7655600A (en) 1,4-dioxacycloalkane-2-one and 1,4-dioxacycloalkene-2-one

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP